Pfizer Secures Three-Year Reprieve From Trump Tariffs: What Indian Investors Need to Know
Pfizer Inc. has secured a three-year reprieve from the tariffs on pharmaceutical imports imposed by US President Donald Trump. Here’s what Indian investors need to know about the deal and its implications on the pharmaceutical sector.